CANO
Get informed when a big investor buys or sells
+ Follow| Market cap | $12.43 Million |
|---|---|
| Enterprise Value | $1.26 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-87.6 |
| Beta | 0.05 |
| Outstanding Shares | 5,278,499 |
| P/E Ratio | -0.03 |
|---|---|
| PEG | -0.01 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.05 |
| Enterprise Value to Revenue | 0.41 |
| Enterprise Value to EBIT | -3.15 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | -10.56 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
This committee's role in developing and scoring tax legislation directly influences corporate tax rates, capital investment incentives, and overall tax burden, which are critical financial factors for Cano Health.
This is a paramount committee for healthcare providers. It controls taxation, trade, and entitlement spending (Medicare, Medicaid), directly impacting hospital profitability, revenue from government programs, and overall financial structure.
This committee directly allocates discretionary federal spending, including funding for health programs (e.g., Medicare, Medicaid), which represent substantial revenue streams for general medical and surgical hospitals.
This committee has direct oversight over health policy, labor laws (a major cost driver for hospitals), and healthcare workforce development, making it highly influential on hospital operations and financial health.
Many general hospitals serve a significant elderly population. This committee's investigations into drug pricing and long-term care quality directly impact hospital costs, revenue, and policy debates critical to their operations.
As a general medical and surgical hospital, Cano Health could be a direct provider for veterans or contract with the Department of Veterans Affairs. This committee's funding decisions and oversight directly impact VA healthcare services.